Deutsche Bank’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-296
| Closed | -$334 | – | 3783 |
|
|
2026
Q1 | $334 | Sell |
296
-6,627
| -96% | -$9.44K | ﹤0.01% | 3601 |
|
|
2025
Q4 | $10.8K | Sell |
6,923
-54,789
| -89% | -$97.8K | ﹤0.01% | 3547 |
|
|
2025
Q3 | $128K | Buy |
61,712
+61,416
| +20,749% | +$141K | ﹤0.01% | 3257 |
|
|
2025
Q2 | $684 | Sell |
296
-37,715
| -99% | -$277K | ﹤0.01% | 3577 |
|
|
2025
Q1 | $297K | Sell |
38,011
-71,837
| -65% | -$570K | ﹤0.01% | 2763 |
|
|
2024
Q4 | $513K | Hold |
109,848
| – | – | ﹤0.01% | 2600 |
|
|
2024
Q3 | $592K | Hold |
109,848
| – | – | ﹤0.01% | 2369 |
|
|
2024
Q2 | $969K | Hold |
109,848
| – | – | ﹤0.01% | 2013 |
|
|
2024
Q1 | $1.29M | Hold |
109,848
| – | – | ﹤0.01% | 1872 |
|
|
2023
Q4 | $1.24M | Hold |
109,848
| – | – | ﹤0.01% | 1907 |
|
|
2023
Q3 | $744K | Sell |
109,848
-11,200
| -9% | -$92.9K | ﹤0.01% | 1906 |
|
|
2023
Q2 | $1.1M | Hold |
121,048
| – | – | ﹤0.01% | 1939 |
|
|
2023
Q1 | $782K | Hold |
121,048
| – | – | ﹤0.01% | 2241 |
|
|
2022
Q4 | $767K | Hold |
121,048
| – | – | ﹤0.01% | 2215 |
|
|
2022
Q3 | $750K | Hold |
121,048
| – | – | ﹤0.01% | 2145 |
|
|
2022
Q2 | $1.07M | Buy |
121,048
+15,000
| +14% | +$112K | ﹤0.01% | 2136 |
|
|
2022
Q1 | $893K | Hold |
106,048
| – | – | ﹤0.01% | 2423 |
|
|
2021
Q4 | $1.08M | Sell |
106,048
-8
| -0% | -$118 | ﹤0.01% | 2384 |
|
|
2021
Q3 | $2.06M | Buy |
106,056
+8
| +0% | +$154 | ﹤0.01% | 2070 |
|
|
2021
Q2 | $1.86M | Hold |
106,048
| – | – | ﹤0.01% | 2298 |
|
|
2021
Q1 | $1.26M | Buy |
106,048
+10,000
| +10% | +$180K | ﹤0.01% | 2512 |
|
|
2020
Q4 | $1.65M | Hold |
96,048
| – | – | ﹤0.01% | 2066 |
|
|
2020
Q3 | $990K | Hold |
96,048
| – | – | ﹤0.01% | 2199 |
|
|
2020
Q2 | $504K | Buy |
96,048
+40,000
| +71% | +$201K | ﹤0.01% | 2637 |
|
|
2020
Q1 | $187K | Buy |
56,048
+10,000
| +22% | +$45.2K | ﹤0.01% | 2982 |
|
|
2019
Q4 | $267K | Buy |
46,048
+4,715
| +11% | +$22.7K | ﹤0.01% | 3051 |
|
|
2019
Q3 | $243K | Buy |
41,333
+8,000
| +24% | +$59.2K | ﹤0.01% | 3070 |
|
|
2019
Q2 | $324K | Hold |
33,333
| – | – | ﹤0.01% | 3541 |
|
|
2019
Q1 | $261K | Buy |
+33,333
| New | +$258K | ﹤0.01% | 3851 |
|
Other funds holding INMB
Deutsche Bank's INMB Position: Q2 2026 in Review
Deutsche Bank sold out of INmune Bio (INMB) in Q2 2026, closing a stake of 296 shares — an estimated $334 sold.
Deutsche Bank first reported a position in INMB in Q1 2019 and held it in 29 quarters. The position peaked at $2.06M in Q3 2021. 82 funds tracked by Wall St. Rank hold INMB as of Q2 2026.
- Deutsche Bank reported no remaining INmune Bio position as of Q2 2026 after selling out during the quarter.
- Deutsche Bank sold 296 INmune Bio shares in Q2 2026, an estimated $334.
- Deutsche Bank first reported a position in INmune Bio in Q1 2019 and held it in 29 quarters.
- Deutsche Bank's INmune Bio position peaked at $2.06M in Q3 2021.
- 82 funds tracked by Wall St. Rank held INmune Bio as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.